Phase I/II study of biweekly nab‐paclitaxel in patients with platinum‐pretreated non‐small cell lung cancer: NJLCG1402

作者
Eisaku Miyauchi,Hisashi Tanaka,Atsushi Nakamura,Toshiyuki Harada,Taku Nakagawa,Mami Morita,Daisuke Jingu,Tomoya Kuda,Shunichi Gamou,Ryota Saito,Akira Inoue
出处
期刊:Thoracic Cancer [Wiley]
卷期号:12 (21): 2886-2893 被引量:6
标识
DOI:10.1111/1759-7714.14149
摘要

Abstract Background NJLCG1402 was a phase I/II trial investigating biweekly nanoparticle albumin‐bound paclitaxel (nab‐PTX) in patients with advanced non‐small cell lung cancer (NSCLC). Methods The study included patients aged ≥20 years with previously treated NSCLC. Nab‐PTX (100–150 mg/m2) was administered biweekly in a 28‐day cycle. The phase I portion was performed to determine the recommended phase II dose of nab‐PTX. In the phase II portion, the primary endpoint was the objective response rate. Secondary endpoints were disease control rate, progression‐free survival, overall survival, and safety. Results A total of 15 patients received biweekly nab‐PTX (100–150 mg/m2) and 12 patients in phase II were treated with 150 mg/m2. In the phase I portion, 150 mg/m2 was determined as the recommended dose. Among those treated with 150 mg/m2, the objective response rate was 22%, and the median progression‐free and overall survival was 3.6 and 11.2 months, respectively. Adverse events grade ≥3 were observed in 39% of patients. Conclusions Biweekly nab‐PTX monotherapy was well tolerated and exhibited favorable antitumor activity in patients with previously treated NSCLC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我爱学习完成签到 ,获得积分10
1秒前
1秒前
sheetung发布了新的文献求助30
1秒前
CYJ发布了新的文献求助10
1秒前
可爱的筝发布了新的文献求助10
1秒前
2秒前
CipherSage的应助被xiao采纳,获得30
3秒前
4秒前
任性蜗牛完成签到,获得积分10
4秒前
漂亮的哈密瓜完成签到,获得积分10
4秒前
彭于晏的应助被糯米糍采纳,获得10
4秒前
小雨快跑完成签到,获得积分10
5秒前
我是老大的应助被cooper采纳,获得10
5秒前
鱼yu完成签到,获得积分10
6秒前
6秒前
小明同学发布了新的文献求助10
6秒前
6秒前
CodeCraft的应助被快乐渊思采纳,获得10
6秒前
Ava的应助被Alice3088采纳,获得10
7秒前
极限001的应助被七七采纳,获得30
7秒前
秋风的应助被学霸颖采纳,获得10
8秒前
彭于晏的应助被leajay采纳,获得10
8秒前
8秒前
研友_VZG7GZ的应助被Postgraduate-Z采纳,获得10
9秒前
秋风的应助被饺子123采纳,获得10
9秒前
9秒前
10秒前
10秒前
10秒前
10秒前
11秒前
彭于晏的应助被CYJ采纳,获得10
11秒前
Maestro_S的应助被韩立采纳,获得10
11秒前
李健的应助被123采纳,获得10
11秒前
可爱的筝完成签到,获得积分20
12秒前
12秒前
个性尔琴完成签到,获得积分10
12秒前
QQ发布了新的文献求助10
13秒前
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163922
求助须知:如何正确求助?哪些是违规求助? 9558007
关于积分的说明 21743214
捐赠科研通 7754605
什么是DOI,文献DOI怎么找? 3428426
关于科研通互助平台的介绍 2553053
邀请新用户注册赠送积分活动 2473048